The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against novel viral variants
Efi Makdasi, Anat Zvi, Ron Alcalay, Tal Noy-Porat, Eldar Peretz, Adva Mechaly, Yinon Levy, Eyal Epstein, Theodor Chitlaru, Ariel Tennenhouse, Moshe Aftalion, David Gur, Nir Paran, Hadas Tamir, Oren Zimhony, Shay Weiss, Michal Mandelboim, Ella Mendelson, Neta Zuckerman, Ital Nemet, Limor Kliker, Shmuel Yitzhaki, Shmuel C. Shapira, Tomer Israely, Sarel J. Fleishman, Ohad Mazor, Ronit Rosenfeld
bioRxiv 2021.04.01.438035; doi: https://doi.org/10.1101/2021.04.01.438035